SENSEX NIFTY

Indian Pharma

Jul 30, 2014 at 10:40 | Source: CNBC-TV18
Mobius, Executive Chairman, Templeton Emerging Markets Group, Franklin Templeton Investments has been betting big on emerging markets and sees them outperforming developed markets going ahead.
Jul 28, 2014 at 16:35 | Source: PTI
The global brokerage major believes the Indian equity markets may consolidate but there is still room for bullishness. "Markets may consolidate after the run up but significant downside may be limited," the report said.
Jul 28, 2014 at 11:07 | Source: Moneycontrol.com
According to Ajay Jain, CEO of astromoneyguru.com, pharma, software, media and oil & gas may show positive move in Indian stock market. "Crude oil may show positive movement due to geo-political tension," he adds.
Jul 23, 2014 at 10:47 | Source: CNBC-TV18
With key event the Union Budget out of markets way, Jeff Chowdhry, head of emerging market equities, F&C Investments sees big-sized global funds to drive the Indian stock market from hereon.
Jul 23, 2014 at 10:42 | Source: Moneycontrol.com
With DPCO coverage extending to almost about 40 percent of the industry, the profitability in the domestic business of pharma companies is likely to come under pressure, says an ICRA report.
Jul 22, 2014 at 12:59 | Source: Moneycontrol.com
Over the past two weeks, the brokerahe house met with nearly sixty investors with practically every investor has a bullish stance on Indian equities.
Jul 21, 2014 at 17:48 | Source: Moneycontrol.com
Updates In The Indian Pharma Sector
Jul 21, 2014 at 08:24 | Source: CNBC-TV18
Reliance Industries | HDFC | HDFC Bank | Sun Pharma | Ranbaxy Labs | Wockhardt | Coal India | Hindalco Industries | Kotak Mahindra Bank | MCX India | Financial Technologies | UltraTech Cement | SKF India | Clariant Chemicals | Motilal Oswal | Oberoi Realty and Ramco Systems are stocks, which are in the news today.
Jul 19, 2014 at 16:08 | Source: Moneycontrol.com
Last week the Bombay High Court upheld the compulsory license granted to Indian pharma company Natco for the sale of a generic version of Bayer's anti-cancer drug Nexavar. Here's a look back at the first legal challenge against a compulsory license in India.
Jul 18, 2014 at 08:16 | Source: CNBC-TV18
TCS | Mindtree | Bajaj Holdings | Rallis India | Gammon Infrastructure | Jet Airways | State Bank of India | Repco Home Finance | Pantaloons Fashion Retail | Sun Pharma | Ranbaxy Labs | Indian Hotels | Cipla | Mahindra and Mahindra | Muthoot Finance | SKS Microfinance | Tata Power and Zee Entertainment are stocks, which are in the news today.
Messages on Indian Pharma »

Accolade

Gold Member

28 Followers

Dion Global  

Parvinder Singh Father of Malvinder and Shivinder built Ranbaxy from the scratch. Made it one of the most respected Indian pharma company globally. Had Parvinder alive, Ranbaxy would never have been sold off to Dia Ichi. Unfortunately like father not sons. Sons are manipulators. Sooner or later

10.57 PM Jul 4th

sikandar

Gold Member

10 Followers

Dr Reddys Labs  

to be the best company. But Sun set benchmarks in the Indian Pharma space in terms of high growth and high profitability. Of course, Sun is an admirable challenge and I think they have done it brilliantly. Their profitability has been industry leading from a long time. However, I don`t feel that we are less than

9.09 PM Jun 30th

MMB Messenger

Platinum Member

235492 Followers

Other Market Topics  

Will the Indian pharma industries be able to put behind its issues with FDA?

2.52 PM Jun 20th

MMB Messenger

Platinum Member

235492 Followers

Cipla  

Are you bullish on the Indian pharma sector?

3.21 PM Jun 19th

MMB Messenger

Platinum Member

235492 Followers

Cipla  

Are you bullish on Indian pharma sector?

1.40 PM Jun 19th

MMB Messenger

Platinum Member

235492 Followers

Other Market Topics  

Do you expect more such deals in the Indian pharma space?

8.35 PM Jun 11th

stocktin

Platinum Member

51 Followers

Biocon  

stage from Indian pharma companies be it Suven ,Glenmark ,Dr REddy, Cadilla,Sparc,Piramal life sciences & Biocon.For all u know innovation cd be the theme of this bull mkt in general also. The Indian pharma has managed to do wht the IT never even tried.So for me there is no choice of shifting

6.06 PM Jun 7th

smallman

Platinum Member

52 Followers

Wockhardt  

I donot think that ban by USFDA on Indian Pharma companies were simple Administrative/Hygenic decision. These were Political decision too, because India was reluctant to honour Patent Rights as approved by USFDA, in toto. I also expect that Modi`s visit to USA in September would improve the status

10.52 AM Jun 6th

01051982

New Member

1 Followers

Wockhardt  

It takes 2 to 3 years to get USFDA approval after getting alerts.( Considering the case of aurobindo pharma & other Indian pharma companies).Chikhalthana plant got fda alert n November 2013 so the plant will get approval by the end of FY 16 or in FY 17.If US plant get FDA alert ( Most likely

1.42 PM Jun 5th

cjvora

Gold Member

31 Followers

Sun Pharma  

sure touch sun best indian pharma stock gem of pharma stock 700 in short term and 1 year time touch 1000......just accumulate this stock and hold it tight for long term,sure big profit get!....good luck.

11.17 AM Jun 3rd

News across the web »
Jun 09, 2014 at 21:33 | Source: Economic Times
May 05, 2014 at 15:41 | Source: Business Today
Explore Moneycontrol

Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.